<DOC>
	<DOCNO>NCT01968993</DOCNO>
	<brief_summary>nanOss Bioactive approve use U.S . The purpose study compare fusion result posterolateral spine use nanOss Bioactive mixed autograft bone bone marrow aspirate ( BMA ) one side autograft alone opposite side treat level ( ) . It hypothesize use nanOss Bioactive result fusion 12 month , CT evidence bridge trabecular bone , less 3mm translational motion , less 5 degree angular motion .</brief_summary>
	<brief_title>Comparison nanOss Bioactive With Autograft Bone Marrow Aspirate Autograft Posterolateral Spine</brief_title>
	<detailed_description>The post market clinical investigation design assess instrumented posterolateral fusion ( PLF ) use nanOss Bioactive bone void filler autograft bone bone marrow aspirate patient symptomatic spinal stenosis secondary degenerative disc disease Grade 1 spondylolisthesis one two adjacent level L2-S1 . Preoperatively , participant provide his/her medical history complete self assessment form . The investigator perform clinical evaluation x-ray perform recent x-rays available . Participants undergo instrumented PLF interbody fusion device ( autograft allograft ) use nanOss Bioactive combination autograft bone bone marrow aspirate one posterolateral gutter autograft alone opposite posterolateral gutter . Following surgery , operative discharge information collect clinical evaluation perform prior discharge . Participants evaluate 6 12 month postoperatively . One investigational site participate long-term followup 24 month . Each participant complete x-ray self assessment document . A CT scan perform 12 month postoperative visit evaluate independent radiologist assess fusion result . Complication data record throughout study .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>least 18 year age skeletally mature . must symptomatic spinal stenosis and/or spondylolisthesis degenerative disc disease ( DDD ) one two adjacent level L2S1 require fusion . must complete minimum three month unsuccessful conservative , nonoperative care . must discogenic back pain without leg pain . DDD must confirm MRI CT scan follow discography ( necessary ) . must score least 40 % Oswestry Disability Index . must score least 4 10 cm Visual Analog Scale back pain . must able comply protocol 's followup schedule . must understand sign inform consent document . symptomatic 2 level . previous fusion surgery lumbar level without instrumentation ( prior discectomy , laminotomy , laminectomy nucleolysis operative ( involve ) level &gt; 6 month permit ) . 50 % spondylolisthesis . lumbar scoliosis great 11 degree . osteoporosis , osteopenia , osteomalacia , Paget 's disease metabolic bone disease . spinal tumor . active arachnoiditis . fracture epiphyseal plate fracture stabilization fracture possible . impaired calcium metabolism . active infection surgical site infection . rheumatoid arthritis autoimmune disease chronic steroid use ( used steroid one month within last 6 month ) medical condition require treatment drug know interfere bone healing . systemic disease AIDS , HIV , hepatitis ( active ) , tuberculosis . morbid obesity define body mass index ( BMI ) &gt; 40 weight 100lbs ideal body weight . smoker unless patient agrees quit least 2 week prior duration study , confirm carboxyhemoglobin test prior surgery . psychosocial disorder would preclude accurate evaluation history substance abuse . active malignancy except nonmelanoma skin cancer ; history invasive malignancy unless treat remission least five year . documented allergy porcine collagen titanium pregnancy , interested become pregnant next four year . participation another investigational study within 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Degenerative Disc Disease</keyword>
</DOC>